Remepy is Pioneering Hybrid Drugs™. 
We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™.

Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. 
The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. 

Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine  Remepy’s Digital Molecule™ and traditional drug components.

Pharmaceutical

Remepy

Or Shoval

Sheila Oren

Michal Tsur

Lior Benderski

Shai Elrich

Shahar Shelly

Nira Saporta

Jonathan Amit - Kanarek

Amir Amedi

The Engineering Team at Remepy is responsible for developing the cutting-edge software components known as Digital Molecules™. This involves crafting the digital interventions and treatment protocols that integrate seamlessly with traditional drug components to form Hybrid Drugs™. The team includes Full Stack Developers who handle both front-end and back-end development, Software Developers who focus on creating robust code for the digital treatments, and UI Designers who ensure that the user experience is intuitive and effective. Together, they work to enhance brain functions, boost neuroplasticity, and optimize drug performance through advanced software solutions.

Engineering Team

Leadership Team

Medical and Clinical Team

Engineering Team

About

Team members

Other teams at Remepy

Leadership Team

Medical and Clinical Team